Browsing by Author Ma, Qingyang
Showing results 1 to 3 of 3
| Issue Date | Title | Author(s) |
| Sep-2021 | IBI362 (LY3305677), a weekly-dose GLP-1 and glucagon receptor dual agonist, in Chinese adults with overweight or obesity: A randomised, placebo-controlled, multiple ascending dose phase 1b study | Ji, Linong; Jiang, Hongwei; An, Pei; Deng, Huan; Liu, Meng; Li, Li; Feng, Liqi; Song, Baili; Han-Zhang, Han; Ma, Qingyang; Qian, Lei |
| 2023 | Pharmacokinetic/LDL-C and exposure-response analysis of tafolecimab in Chinese hypercholesterolemia patients: Results from phase I, II, and III studies | Yan, Shuling; Zhao, Xia; Xie, Qiushi; Du, Weijuan; Ma, Qingyang; Zhu, Tongkang; Deng, Huan; Qian, Lei; Zheng, Shirui; Cui, Yimin |
| 14-Dec-2023 | A phase 2 randomised controlled trial of mazdutide in Chinese overweight adults or adults with obesity | Ji, Linong; Jiang, Hongwei; Cheng, Zhifeng; Qiu, Wei; Liao, Lin; Zhang, Yawei; Li, Xiaoli; Pang, Shuguang; Zhang, Lihui; Chen, Liming; Yang, Tao; Li, Yan; Qu, Shen; Wen, Jie; Gu, Jieyu; Deng, Huan; Wang, Yanqi; Li, Li; Han, Han-Zhang; Ma, Qingyang; Qian, Lei |
